LIFECORE BIOMEDICAL, INC. \DE\ (ticker: LFCR) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of LFCR's SEC filings surfaces 10 active risk signals, including 9 late-filing signals, and 1 auditor-change signal. LFCR reported $557.56M in revenue and -$14.98M for the period ending 2019-05-26, with operating cash flow of $4.70M. Cash and equivalents stood at $20.80M. Total assets of $225.50M exceed total liabilities of $204.72M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
LFCR SEC Filings
Full cached SEC EDGAR filing history for LFCR, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.